Federal authorities this week sued a Chicago psychiatrist accusing him of taking kickbacks from drug companies and committing fraud by prescribing antipsychotic medications for thousands of mentally ill patients in nursng homes. The suit against Dr. Michael Reinstein represents the largest civil case alleging prescription medication fraud. Authorities say that Reinstein submitted over 140,000...
Continue reading…
Category: Pharmaceutical
U.S. says foreign bribery by big drug makers widespread in emerging markets: penalties harsher
Global drug manufacturers are shelling out millions of dollars to settle allegations that they are bribing their way into emerging markets a practice that is in violation of the Foreign Corrupt Practices Act (FCPA) . Harsher penalties are being implemented to deter the practices says the Department Of Justice. Eight of the top 10...
Continue reading…
Boehringer Ingelheim to pay $95 million to settle Whistleblower case for improperly marketing stroke drug
Connecticut based Boehringer Ingelhein Pharmaceuticals Inc. will pay $95 million to end allegations of improper promotion of the stroke prevention drug Aggrenox, the chronic obstructive pulmonary disease (COPD) drugs Atrovent and Combivent. The Food and Drug Administration has approved Aggrenox to prevent secondary strokes, Combivent to treat symptoms of bronchospasm with COPD. according to...
Continue reading…
Critically Ill children in hospitals frequently get drugs off-label exposing them to risk
A recent study at the Primary Children's Medical Center in Salt Lake showed that a majority of drugs used in the pediatric intensive care unit (PICU), are used in an off-label manner, exposing the patients to meds that may not have been studied in children. Of 335 drugs used in a PICU over a...
Continue reading…
Big Pharma Medicare Fraud “Settlement: $35,000,000
The Plaintiff, brought a claim on behalf of the United States against a medical supply company allegedly defrauding Medicare by improperly submitting reimbursement claims for various diabetic and nebulizer products. The United States intervened in the case and, ultimately, the United States was able to recover $35,000,000.00
Physician Blows Whistle on Big Pharma Studies in New Book: Bad Pharma
English physician Ben Goldacre has written a book called Bad Pharma excerpts of which are now being published. I haven't read the whole book yet, which is being published by Fourth Estate next week, but the excerpts are exactly what the doctor ordered--a clear, precise excoriation of the big drug industry from the point...
Continue reading…
WHISTLEBLOWER SAYS ABBOTT LABS FALSELY MARKETED TRICOR CHOLESTEROL DRUG
A former Abbott labs saleswoman has filed a federal whistleblower lawsuit saying the company illegally promoted its cholesterol drug TriCor for uses not approved by regulators including for use preventing cardiac health risks with patients with diabetes. That sales person Amy Bergman said that she was trained, directed, incentivized and encouraged by Abbott to...
Continue reading…
OFF LABEL USE OF CANCER DRUG TARGRETIN FOR ALZHEIMER’S QUESTIONED IN MEDICAL JOURNAL
A drug Targretin, approved by the FDA only for use in the treatment of cutaneous T-cell lymphoma, a form of cancer, is being prescribed by some doctors for treatment of Alzheimer's based on a published study suggesting that it may relieve symptoms of Alzheimer's Disease in mice. However, in an editorial published in the...
Continue reading…
Pharma Whistleblower Twice Over Lilly then AstraZeneca
James Wetta is a multi-millionaire from his activities as a whistleblower of the pharma industry not once by twice and his recent revelations concerning AstraZeneca will result in $45 million to him. The former AstraZeneca sales rep filed a whistleblower lawsuit against the company in 2004 and Astra revealed last week that it would...
Continue reading…
GHOST-WRITTEN SCIENTIFIC PUBLICATIONS AT CORE OF GLAXO CASE–HOW FREQUENT IS THIS?
The largest health care settlement in history reached with GlaxoSMithKline last month revealed that the company paid more than 20 academic researchers to attach their names to a ghost-written article that misrepresented the safety and efficacy of the depression drug Paxil for children. Glaxo paid the government over 3 Billion dollars to resolve the...
Continue reading…